Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes

Internal Medicine Journal

Volumn 40, Issue 6, 2010, Pages 437-442

  Hwang, S T ^a   Cho, Y K ^a   Yun, J W ^a   Park, J H ^a   Kim, H J ^a   Park, D I ^a   Sohn, C I ^a   Jeon, W K ^a   Kim, B I ^a   Rhee, E J ^a   Oh, K W ^a   Lee, W Y ^a   Jin, W ^b  

^a Sungkyunkwan University   (South Korea)

^b Gachon University   (South Korea)

Author keywords

microalbuminuria; Non alcoholic fatty liver disease; prediabetes; type 2 diabetes

Indexed keywords

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER FUNCTION TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; SCREENING; ULTRASOUND; WAIST CIRCUMFERENCE;

ADULT; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 77953838107     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01979.x     Document Type: Article

References (30)

1. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008 51 : 714 725.
2. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003 139 : 137 147.
3. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin- dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997 157 : 1413 1418.
4. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 286 : 421 426.
5. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 2004 110 : 32 5.
6. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS64). Kidney Int 2003 63 : 225 232.
7. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its complications: Report of a WHO Consultation.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
9. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004 140 : 167 174.
10. Lin CC, Liu CS, Li TC, Chen CC, Li CI, Lin WY. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest 2007 37 : 783 790.
11. Neuxchwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003 37 : 1202 1219.
12. Mulhall BP, Ong JP, Younssi ZM. Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 2002 17 : 1136 1143.
13. Adams LA, Angulo P, Lindir KD. Nonalcoholic fatty liver disease. CMAJ 2005 172 : 899 905.
14. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000 132 : 112 117.
15. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto T et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005 22 : 1141 1145.
16. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999 30 : 1356 1362.
17. Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L et al. Increased prevalence of fatty liver in arterial hypertensive patients. Role of insulin resistance. Gut 2004 53 : 1020 1023.
18. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000 45 : 1929 1934.
19. Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008 19 : 1564 1570.
20. Chang YS, Ryu SH, Sung EJ, Woo HY, Oh EO, Cha KS et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metab Clin Exp 2008 57 : 569 576.
21. American Diabetes Association (ADA). Clinical practice recommendations. Diabetes Care 2007 30 (Suppl 1 S42 7.
22. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003 38 : 954 961.
23. Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008 51 : 444 450.
24. Targher G, Bertolini L, Scala L, Zopppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabetic Medicine 2005 22 : 1354 1358.
25. Angulo P. NAFLD, obesity, and bariatric surgery. Gastroenterology 2006 130 : 1848 1852.
26. Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007 27 : 130 143.
27. Targher G, Bertolini L, Scala L, Zenari L, Lippi G, Franchini M et al. Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis. Diabetes Care 2007 30 : e31 2.
28. Targher G. Relationship between high-sensitive C-reactive protein levels and liver histology in subjects with non-alcoholic fatty lever disease. J Hepatol 2006 45 : 879 881.
29. Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, Ohata K et al. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 2006 26 : 39 45.
30. Saadeh S, Younossi ZM, Remer EM Gramlich T, Ong JP, Hurley M et al. The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 2002 123 : 745 750.